DexCom (DXCM) News Today $89.07 +4.98 (+5.92%) Closing price 02/14/2025 04:00 PM EasternExtended Trading$89.20 +0.14 (+0.15%) As of 02/14/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period DexCom's SWOT analysis: stock faces challenges amid growth potentialFebruary 17 at 6:22 PM | msn.comDexCom Q4 Earnings TranscriptFebruary 17 at 7:34 AM | marketbeat.comBaillie Gifford & Co. Sells 404,874 Shares of DexCom, Inc. (NASDAQ:DXCM)Baillie Gifford & Co. trimmed its stake in shares of DexCom, Inc. (NASDAQ:DXCM - Free Report) by 2.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 14,612,792 shares of the medical device company'February 17 at 5:36 AM | marketbeat.comRhumbline Advisers Reduces Stake in DexCom, Inc. (NASDAQ:DXCM)Rhumbline Advisers lowered its stake in DexCom, Inc. (NASDAQ:DXCM - Free Report) by 3.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 776,229 shares of the medical device company's stocFebruary 17 at 3:57 AM | marketbeat.comVontobel Holding Ltd. Trims Stock Position in DexCom, Inc. (NASDAQ:DXCM)Vontobel Holding Ltd. lessened its holdings in shares of DexCom, Inc. (NASDAQ:DXCM - Free Report) by 50.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 35,024 shares of the medical device company'sFebruary 17 at 3:37 AM | marketbeat.comDexCom (NASDAQ:DXCM) Price Target Raised to $103.00February 17 at 2:47 AM | americanbankingnews.comLeerink Partnrs Issues Positive Estimate for DexCom EarningsDexCom, Inc. (NASDAQ:DXCM - Free Report) - Investment analysts at Leerink Partnrs boosted their Q1 2025 earnings estimates for DexCom in a research note issued on Friday, February 14th. Leerink Partnrs analyst M. Kratky now forecasts that the medical device company will post earnings per share ofFebruary 17 at 1:49 AM | marketbeat.comDexCom, Inc. (NASDAQ:DXCM) Q4 2024 Earnings Call TranscriptFebruary 16 at 10:59 PM | msn.comEmpire Life Investments Inc. Raises Holdings in DexCom, Inc. (NASDAQ:DXCM)Empire Life Investments Inc. boosted its holdings in shares of DexCom, Inc. (NASDAQ:DXCM - Free Report) by 6.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 89,263 shares of the medical device compaFebruary 16 at 7:08 AM | marketbeat.comDexCom, Inc. (NASDAQ:DXCM) Shares Acquired by Congress Asset Management Co.Congress Asset Management Co. grew its stake in DexCom, Inc. (NASDAQ:DXCM - Free Report) by 5,456.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,356,941 shares of the medical device company's stock aFebruary 16 at 5:08 AM | marketbeat.comNew York State Teachers Retirement System Cuts Stock Holdings in DexCom, Inc. (NASDAQ:DXCM)New York State Teachers Retirement System lowered its stake in DexCom, Inc. (NASDAQ:DXCM - Free Report) by 1.7% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 360,161 shares of the medical dFebruary 16 at 4:15 AM | marketbeat.comChevy Chase Trust Holdings LLC Cuts Holdings in DexCom, Inc. (NASDAQ:DXCM)Chevy Chase Trust Holdings LLC cut its position in shares of DexCom, Inc. (NASDAQ:DXCM - Free Report) by 4.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 205,088 shares of the medical device company's stock after selling 9,886 shaFebruary 16 at 4:14 AM | marketbeat.comAsset Management One Co. Ltd. Has $19.53 Million Holdings in DexCom, Inc. (NASDAQ:DXCM)Asset Management One Co. Ltd. raised its stake in shares of DexCom, Inc. (NASDAQ:DXCM - Free Report) by 3.4% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 243,375 shares of the medical device company's stock after purchasing an additional 7,February 16 at 3:56 AM | marketbeat.comMorgan Stanley Boosts DexCom (NASDAQ:DXCM) Price Target to $82.00February 16 at 3:31 AM | americanbankingnews.comMorgan Stanley Increases DexCom (NASDAQ:DXCM) Price Target to $82.00Morgan Stanley upped their price objective on shares of DexCom from $75.00 to $82.00 and gave the company an "equal weight" rating in a research note on Friday.February 15 at 9:32 AM | marketbeat.comDexCom (NASDAQ:DXCM) Given New $103.00 Price Target at Canaccord Genuity GroupCanaccord Genuity Group lifted their target price on DexCom from $99.00 to $103.00 and gave the stock a "buy" rating in a report on Friday.February 15 at 9:32 AM | marketbeat.comDexCom, Inc. (NASDAQ:DXCM) Stake Boosted by Banque Pictet & Cie SABanque Pictet & Cie SA increased its position in shares of DexCom, Inc. (NASDAQ:DXCM - Free Report) by 12.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 131,809 shares of the medical dFebruary 15 at 6:59 AM | marketbeat.comCompagnie Lombard Odier SCmA Cuts Stock Position in DexCom, Inc. (NASDAQ:DXCM)Compagnie Lombard Odier SCmA lessened its stake in DexCom, Inc. (NASDAQ:DXCM - Free Report) by 10.9% in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 134,810 shares of the medical device company's stock after selling 16,473 shareFebruary 15 at 6:25 AM | marketbeat.comTactile Systems Technology (NASDAQ:TCMD) and DexCom (NASDAQ:DXCM) Critical ComparisonFebruary 15 at 4:14 AM | americanbankingnews.com2DXCM : DexCom Unusual Options ActivityFebruary 14 at 9:08 PM | benzinga.comDexCom’s Optimistic Earnings Call: Growth Amid ChallengesFebruary 14 at 7:06 PM | tipranks.comDexCom (NASDAQ:DXCM) Issues Earnings ResultsDexCom (NASDAQ:DXCM - Get Free Report) posted its quarterly earnings results on Thursday. The medical device company reported $0.45 earnings per share for the quarter, missing the consensus estimate of $0.50 by ($0.05). DexCom had a return on equity of 31.40% and a net margin of 17.22%.February 14 at 4:49 PM | marketbeat.comAnalyst Cautiously Optimistic On DexCom As Competitive Pressures LoomFebruary 14 at 3:43 PM | benzinga.comAnalyst Cautiously Optimistic On DexCom As Competitive Pressures LoomFebruary 14 at 3:04 PM | benzinga.comDexCom Analysts Increase Their Forecasts After Q4 EarningsFebruary 14 at 9:41 AM | benzinga.comKestra Private Wealth Services LLC Buys 3,574 Shares of DexCom, Inc. (NASDAQ:DXCM)Kestra Private Wealth Services LLC boosted its stake in DexCom, Inc. (NASDAQ:DXCM - Free Report) by 47.8% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 11,047 shares of the medical device company's stocFebruary 14 at 3:54 AM | marketbeat.comAnalysts Offer Insights on Healthcare Companies: Blueprint Medicines (BPMC) and Dexcom (DXCM)February 14 at 3:22 AM | markets.businessinsider.comDexCom Inc (DXCM) Q4 2024 Earnings Call Highlights: Revenue Growth Amid Margin ChallengesFebruary 14 at 2:33 AM | gurufocus.comDexCom’s (NASDAQ:DXCM) Q4: Beats On RevenueFebruary 13, 2025 | msn.comDexCom (DXCM) Q4 2024 Earnings Call TranscriptFebruary 13, 2025 | msn.comDexCom, Inc. (DXCM) Q4 2024 Earnings Call TranscriptFebruary 13, 2025 | seekingalpha.comDexCom: Revenue Up, EPS Misses MarkFebruary 13, 2025 | fool.comDexCom, Inc. 2024 Q4 - Results - Earnings Call PresentationFebruary 13, 2025 | seekingalpha.comDexCom Inc Q4 2024 Earnings: Revenue Surpasses Estimates at $1. ...February 13, 2025 | gurufocus.comDexCom Options Trading: A Deep Dive into Market SentimentFebruary 13, 2025 | benzinga.comDexCom options imply 6.7% move in share price post-earningsFebruary 13, 2025 | markets.businessinsider.comDexCom affirms FY25 revenue view of $4.60B, consensus $4.61BFebruary 13, 2025 | markets.businessinsider.comDexCom shares fall 6% on Q4 earnings missFebruary 13, 2025 | msn.comDexcom beats fourth-quarter sales, reiterates 2025 revenue forecastFebruary 13, 2025 | reuters.comMFG Wealth Management Inc. Buys New Position in DexCom, Inc. (NASDAQ:DXCM)MFG Wealth Management Inc. purchased a new stake in DexCom, Inc. (NASDAQ:DXCM - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund purchased 20,239 shares of the medical device company's stock, valued at apFebruary 13, 2025 | marketbeat.comLouisiana State Employees Retirement System Sells 3,700 Shares of DexCom, Inc. (NASDAQ:DXCM)Louisiana State Employees Retirement System trimmed its holdings in shares of DexCom, Inc. (NASDAQ:DXCM - Free Report) by 7.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 49,500 shares of the medical devFebruary 13, 2025 | marketbeat.comIs DexCom, Inc. (DXCM) the Best Medical Device Stock to Buy?February 13, 2025 | msn.comDexCom (DXCM) To Report Earnings Tomorrow: Here Is What To ExpectFebruary 13, 2025 | msn.comMotorola, DexCom, Airbnb lead earnings reports ThursdayFebruary 12, 2025 | investing.comBofA maintains Buy on DexCom stock with $90 targetFebruary 11, 2025 | msn.comEquitable Trust Co. Has $925,000 Holdings in DexCom, Inc. (NASDAQ:DXCM)Equitable Trust Co. cut its holdings in shares of DexCom, Inc. (NASDAQ:DXCM - Free Report) by 34.8% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 11,900 shares of the medical device company's stockFebruary 11, 2025 | marketbeat.comSavant Capital LLC Has $8.58 Million Stock Holdings in DexCom, Inc. (NASDAQ:DXCM)Savant Capital LLC grew its position in DexCom, Inc. (NASDAQ:DXCM - Free Report) by 9.7% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 110,383 shares of the medical device company's stock after purchasing an additional 9,731 shares dFebruary 11, 2025 | marketbeat.comAngeles Wealth Management LLC Invests $245,000 in DexCom, Inc. (NASDAQ:DXCM)Angeles Wealth Management LLC acquired a new stake in DexCom, Inc. (NASDAQ:DXCM - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 3,145 shares of the medical device company'sFebruary 11, 2025 | marketbeat.comBofA says use DexCom’s stock move as buying opportunityFebruary 10, 2025 | markets.businessinsider.comSumitomo Mitsui DS Asset Management Company Ltd Buys 6,290 Shares of DexCom, Inc. (NASDAQ:DXCM)Sumitomo Mitsui DS Asset Management Company Ltd increased its stake in DexCom, Inc. (NASDAQ:DXCM - Free Report) by 15.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 47,263 shaFebruary 10, 2025 | marketbeat.com Get DexCom News Delivered to You Automatically Sign up to receive the latest news and ratings for DXCM and its competitors with MarketBeat's FREE daily newsletter. Email Address DXCM Media Mentions By Week DXCM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DXCM News Sentiment▼0.680.41▲Average Medical News Sentiment DXCM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DXCM Articles This Week▼5322▲DXCM Articles Average Week Get DexCom News Delivered to You Automatically Sign up to receive the latest news and ratings for DXCM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Medtronic News Today Becton, Dickinson and Company News Today Edwards Lifesciences News Today IDEXX Laboratories News Today ResMed News Today STERIS News Today Insulet News Today Baxter International News Today Hologic News Today Globus Medical News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:DXCM) was last updated on 2/17/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredTop Picks for Trump’s Pro-Crypto America10,000% Crypto Opportunities in 2025 27 of the brightest minds in crypto share exclusive intel… Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DexCom, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share DexCom With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.